Early treatment for multiple myeloma and more news from ASH

Plus: Biopharma leaders on the future of blood cancer treatment

December 10, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Early treatment may delay or prevent multiple myeloma in high-risk patients, according to new study Study finds benefit when Johnson & Johnson drug is given in the precancerous stage known as smoldering myeloma. By Angus Chen Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma, and Blenrep's comeback story keeps rolling on. By Angus Chen, Adam Feuerstein, Jonathan Wosen, and Meghana Keshavan Biopharma leaders lay out vision for the future of blood cancer treatment Drug developers are shifting their thinking from treating patients until their blood cancer progresses to treating to cure By Adam Feuerstein, Jonathan Wosen, Angus Chen, and Meghana Keshavan Rick Bern Photography STAT+ | Oncology startup launches with $52 million, reflecting a new 'austerity-driven' financing reality The company had originally set out to raise as much as $70 million. The shortfall reflects what an executive described as a new "austerity-driven" reality. By Allison DeAngelis STAT+ | GSK myeloma medicine improves survival in trial, another step in the drug's revival GSK reported at #ASH2024 that its drug Blenrep helped patients live longer in a pivotal trial. By Andrew Joseph Study paints clearer picture of disadvantaged leukemia patients' struggle to get bone marrow transplants The findings, at #ASH 2024, suggest that access rather than therapy efficacy is the main issue facing AML patients from lower socioeconomic backgrounds By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser